HLA DRB1 alleles and hepatitis C virus infection in chronic kidney disease patients

Renal Failure

Volumn 35, Issue 3, 2013, Pages 386-390

  Shaheen, Noha Mohamed Hosni ^a   Soliman, Amin Roshdy ^a   El Khashab, Sahier Omar ^a   Hanna, Mariam Onsy Farag ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Dialysis; Hepatitis C virus; Human leukocyte antigens; Infection; Renal failure

Indexed keywords

VIRUS ANTIBODY; HLA DRB1 ANTIGEN;

ALLELE; ARTICLE; CHRONIC KIDNEY DISEASE; GENE; GENE FREQUENCY; HEMODIALYSIS; HEPATITIS C; HETEROZYGOSITY; HLA DRB1 GENE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; CHRONIC KIDNEY FAILURE; COMPLICATION; GENETICS; RENAL REPLACEMENT THERAPY;

ALLELES; GENE FREQUENCY; HEPATITIS C; HLA-DRB1 CHAINS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 84875036639     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.761038     Document Type: Article

References (28)

1. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet. 2003;362:2095-2100
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436-2441
3. Thurairajah PH, Hegazy D, Chokshi S, et al. Hepatitis C virus (HCV)-specificTcell responses in injectiondruguserswithapparent resistance toHCV infection. J Infect Dis. 2008;198(12):1749-1755
4. Plancoulaine S, Mohamed MK, Arafa N, et al. Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut. 2008;57(9):1268-1274
5. Perrella A, Grattacaso S, d'Antonio A, et al. Evidence of hepatitis C virus-specific interferon gamma-positive T cells in health care workers in an infectious disease department. Am J Infect Control. 2009;37(5):426-429
6. Kubitschke A, Bahr MJ, Aslan N, et al. Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viremia. Eur J Clin Invest. 2007;37(1):54-64
7. Bronowicki JP, Vetter D, Uhl G, et al. Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis. 1997;176:518-522
8. Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis. 1997;176:859-866
9. Al-Sherbiny M, Osman A, Mohamed N, et al. Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am J Trop Med Hyg. 2005;73:44-49
10. Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev. 2009;22(2):370-385
11. Verdon R, Pol S, Landais P, et al. Absence of association between HLA antigens and chronicity of viral hepatitis in hemodialyzed patients. J Hepatol. 1994;21(3):388-393
12. Congia M, Clemente MG, Dessi C, et al. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology. 1996;24(6):1338-1341
13. Kuniholm MH, Kovacs A, Gao X, et al. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology. 2010;51(5):1514-1522
14. Hassan NF, El Ghorab NM, Abdel Rehim MS, et al. HIV infection in renal dialysis patients in Egypt. AIDS. 1994;8(6):853
15. Hassan AA, Khalil R. Hepatitis C in dialysis patients in Egypt: Relationship to dialysis duration, blood transfusion, and liver disease. Saudi J Kidney Dis Transpl. 2000;11:72-73
16. Hraber P, Kuiken C, Yusim K. Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection. Hepatology. 2007;46(6):1713-1721
17. Neumann-Haefelin C, Thimme R. Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection. Genes Immun. 2007;8(3):181-192
18. Chen DF, Endres W, Kliem V, et al. No significant influence of HLA determinants on susceptibility to hepatitisC virus infection in Caucasian patients with end-stage renal disease. Liver. 1996;16(6):384-389
19. Dinçer D, Besisik F, Oǧuz F, et al. Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients. Int J Artif Organs. 2001;24(4):212-214
20. Nolan D, Gaudieri S, Mallal S. Host genetics and viral infections: Immunology taught by viruses, virology taught by the immune system. Curr Opin Immunol. 2006;18:413-421
21. Sulowicz W, Radziszewski A, Chowaniec E. Hepatitis C virus infection in dialysis patients. Hemodial Int. 2007;11(3):286-295
22. NIH Consensus Statement onManagement of Hepatitis C. NIH Consens State Sci Statements. 2002;19(3):1-46
23. Faustini A, Colais P, Fabrizi E, et al. Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups. BMC Infect Dis. 2010;10:97
24. Zekri AR, El-Mahallawy HA,HassanA, et al.HLAalleles in Egyptian HCV genotype-4 carriers. Egypt J Immunol. 2005;12(1):77-86
25. Hadhoud A, Abdulaziz AM, Menawi LA, et al. The relationship between HLA typing and HCV infection and outcome of renal transplantation in HCV positive patients. Exp Clin Transplant. 2003;1(1):19-25
26. Thurairajah PH, Hegazy D, Demaine A, Kaminski ER, Cramp ME. Loss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation. J Infect Dis. 2011;203(6):847-853
27. Warshow UM, Riva A, Hegazy D, et al. Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection. J Viral Hepat. 2012;19(7):501-508
28. Knapp S, Warshow U, Ho KM, et al. A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection. Gastroenterology. 2011;141(1):320-325